ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648316 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648316; 2) Community: the network communities that were significantly associated with the response to NSC 648316; 3) Molecule: the relationships between components within communities and NSC 648316; 4) MDR: the compounds that were significantly associated with the NSC 648316.

NSC Compound Enrichment Correlation
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.00404192617431249 0.48695204
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.00404192617431249 0.463742
NSC 56452 Null 0.00404192617431249 0.22534747
NSC 606985 Camptothecin Derivative 0.00404192617431249 0.45323739
NSC 616348 Irinotecan hydrochloride 0.00404192617431249 0.65366998
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.00404192617431249 0.06912257
NSC 647117 Null 0.00404192617431249 0.42698587
NSC 649307 Null 0.00404192617431249 0.15308644
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.00404192617431249 0.3629412
NSC 686940 Null 0.00404192617431249 0.0077005214
Total:76  Current:11    [First] [Prev] [Next] [Last]